At the tail end of 2022, Click Therapeutics announced it was expanding its partnership with Boehringer Ingelheim focused on developing prescription digital therapeutics for patients with schizophrenia ...

Credit: Getty Images Prescription digital therapeutics represent the evolving intersection of technology and mental health care – but how do clinicians feel about this new era? The recent ...

Senators Shelley Moore Capito, R-W.Va., and Jeanne Shaheen, D-N.H., reintroduced the Access to Prescription Digital Therapeutics (PDT) Act on Thursday to expand access to software-based treatments.

European Digital Therapeutics Market · GlobeNewswire Inc. Dublin, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The "Europe Digital Therapeutics Market, By Country, Competition, Forecast and Opportunities, ...

It's still early days for integrating digital therapeutics into clinical care, said panelists at the 2023 HIMSS Global Health Conference & Exhibition. But they have a role to play when developers ...

As it moves past Pear Therapeutics' downfall, the digital therapeutics industry is looking for a path to regulatory reimbursement and focusing on non-prescription products. Pear Therapeutics, which ...

Digital therapeutics allow health care workers and patients to use software in the management and treatment of disease. The idea spans various health care areas, including mental health, chronic ...

Sens. Shelley Moore Capito, R-W.Va, and Jeanne Shaheen, D-N.H., have reintroduced a bill that would expand access to software-based treatments and create a reimbursement pathway for software that ...

Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will ...

Click Therapeutics, a developer of prescription digital therapeutic products, is adding substance use disorder to its pipeline through a new partnership with addiction medicines maker Indivior. Like ...

Charlotte Jee had fought insomnia her entire adult life. In 2018, chronically exhausted and sick of sleeping pills, Jee, an editor at MIT Technology Review, tested several high-tech solutions that ...

Perspectives on the digital therapeutics industry tend to reveal the bias of the prognosticator as a glass-half-full optimist or glass-half-empty pessimist. Not enough clinical data vs. inadequate ...